BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17726933)

  • 21. Comments on use of mitotane.
    Watson AD
    J Am Vet Med Assoc; 1995 Jan; 206(1):25. PubMed ID: 7744655
    [No Abstract]   [Full Text] [Related]  

  • 22. Medical treatment of canine hyperadrenocorticoidism with o,p'-DDD.
    Lorenz MD; Scott DW; Pulley LT
    Cornell Vet; 1973 Oct; 63(4):646-65. PubMed ID: 4748884
    [No Abstract]   [Full Text] [Related]  

  • 23. Medical treatment of pituitary-dependent hyperadrenocorticism. Mitotane.
    Peterson ME; Kintzer PP
    Vet Clin North Am Small Anim Pract; 1997 Mar; 27(2):255-72. PubMed ID: 9076906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of urine protein content in dogs with pituitary-dependent hyperadrenocorticism.
    Hurley KJ; Vaden SL
    J Am Vet Med Assoc; 1998 Feb; 212(3):369-73. PubMed ID: 9470045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pituitary macroadenomas and macroadenocarcinomas in dogs treated with mitotane for pituitary-dependent hyperadrenocorticism: 13 cases (1981-1986).
    Nelson RW; Ihle SL; Feldman EC
    J Am Vet Med Assoc; 1989 Jun; 194(11):1612-7. PubMed ID: 2753785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of the urine cortisol: creatinine ratio to monitor treatment response in dogs with pituitary-dependent hyperadrenocorticism.
    Guptill L; Scott-Moncrieff JC; Bottoms G; Glickman L; Johnson M; Glickman N; Nelson R; Bertoy E
    J Am Vet Med Assoc; 1997 Apr; 210(8):1158-61. PubMed ID: 9108922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An alternative protocol for the medical management of canine pituitary-dependent hyperadrenocorticism.
    Rijnberk A; Belshaw BE
    Vet Rec; 1988 May; 122(20):486-8. PubMed ID: 3420770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of canine hyperadrenocorticism, using computed tomography.
    Emms SG; Wortman JA; Johnston DE; Goldschmidt MH
    J Am Vet Med Assoc; 1986 Aug; 189(4):432-9. PubMed ID: 3019972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of ACTH stimulation tests to monitor the treatment of canine hyperadrenocorticism.
    Dunn KJ; Herrtage ME; Dunn JK
    Vet Rec; 1995 Aug; 137(7):161-5. PubMed ID: 8553523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased insulin sensitivity and glucose tolerance in spontaneous canine hyperadrenocorticism.
    Peterson ME; Altszuler N; Nichols CE
    Res Vet Sci; 1984 Mar; 36(2):177-82. PubMed ID: 6371957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitotane (o,p'-DDD) treatment of 200 dogs with pituitary-dependent hyperadrenocorticism.
    Kintzer PP; Peterson ME
    J Vet Intern Med; 1991; 5(3):182-90. PubMed ID: 1656032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic availability of o,p'-DDD in normal dogs, fasted and fed, and in dogs with hyperadrenocorticism.
    Watson AD; Rijnberk A; Moolenaar AJ
    Res Vet Sci; 1987 Sep; 43(2):160-5. PubMed ID: 3685628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complications and concurrent disease associated with canine hyperadrenocorticism.
    Nichols R
    Vet Clin North Am Small Anim Pract; 1997 Mar; 27(2):309-20. PubMed ID: 9076910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes mellitus, hyperadrenocorticism, and hypothyroidism in a dog.
    Hess RS; Ward CR
    J Am Anim Hosp Assoc; 1998; 34(3):204-7. PubMed ID: 9590447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pheochromocytoma and hyperadrenocorticism in dogs: six cases (1982-1992).
    von Dehn BJ; Nelson RW; Feldman EC; Griffey SM
    J Am Vet Med Assoc; 1995 Aug; 207(3):322-4. PubMed ID: 7628933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Megavoltage irradiation of pituitary macrotumors in dogs with neurologic signs.
    Théon AP; Feldman EC
    J Am Vet Med Assoc; 1998 Jul; 213(2):225-31. PubMed ID: 9676592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of metyrapone to treat pituitary-dependent hyperadrenocorticism in a cat with large cutaneous wounds.
    Daley CA; Zerbe CA; Schick RO; Powers RD
    J Am Vet Med Assoc; 1993 Mar; 202(6):956-60. PubMed ID: 8468223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computed tomography in the diagnosis of canine hyperadrenocorticism not suppressible by dexamethasone.
    Voorhout G; Stolp R; Lubberink AA; van Waes PF
    J Am Vet Med Assoc; 1988 Mar; 192(5):641-6. PubMed ID: 3372313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical treatment of pituitary-dependent hyperadrenocorticism in dogs: should L-deprenyl (Anipryl) ever be used?
    Peterson ME
    J Vet Intern Med; 1999; 13(4):289-90. PubMed ID: 10449217
    [No Abstract]   [Full Text] [Related]  

  • 40. Distinguishing dogs with functioning adrenocortical tumors from dogs with pituitary-dependent hyperadrenocorticism.
    Feldman EC
    J Am Vet Med Assoc; 1983 Jul; 183(2):195-200. PubMed ID: 6309721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.